Healios AG Announces Addition of Anna Walz to Board of Directors BASEL, Switzerland, April 12, 2022 (GLOBE NEWSWIRE) -- Healios AG, a MedTech company focused on developing and validating digital biomarkers since 2014, announced that Anna Walz has been appointed...

Healios AG Named as a Finalist for the Coveted 2022 Swiss Medtech Award BASEL, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) -- Healios AG, a MedTech company focused on developing and validating digital biomarkers since 2014, has been named one of three finalists for the...

Healios AG Announces Addition of Meg Heim RN, MAS to Board of Directors BASEL, Switzerland, March 28, 2022 (GLOBE NEWSWIRE) -- Healios AG, a MedTech company focused on developing and validating digital biomarkers since 2014, announced that Meg Heim has been appointed to...